文献速递胸部PETCT

深度学习基于治疗前18F-FDG PET/CT无创鉴别非小细胞肺癌病理亚型

Non-invasively Discriminating the Pathological Subtypes of Non-small Cell Lung Cancer with Pretreatment 18F-FDG PET/CT Using Deep Learning.
PubMed 文献 · Acad Radiol · 2023-04-26

该研究回顾性收集189例非小细胞肺癌患者的术前18F-FDG PET/CT图像,按6:2:2随机分为训练、验证及内部/扩展测试队列,训练并优化七种深度学习模型。Mobilenet v2模型在内部测试组(AUC 0.744, AP 0.759)和扩展测试组(AUC 0.767, AP 0.768)表现最佳,决策曲线分析显示患者可从基于该模型的决策中获益。结论认为深度学习模型在NSCLC病理亚型分类方面具有较大潜力。

要点

  • Mobilenet v2模型在内部测试组AUC为0.744,扩展测试组AUC为0.767。
  • 部分深度学习特征与SUVmax及肿瘤大小显著相关(P < 0.05)。
  • 决策曲线分析提示基于Mobilenet v2模型的决策可使患者获益。

诊断标准与关键数值

  • Mobilenet v2模型在内部测试组AUC为0.744,AP为0.759。
  • Mobilenet v2模型在扩展测试组AUC为0.767,AP为0.768。
  • 部分深度学习特征与SUVmax和肿瘤大小显著相关(P < 0.05)。

临床应用与阅片要点

  • 可尝试利用基于18F-FDG PET/CT的深度学习模型辅助无创预测NSCLC病理亚型。
  • 深度学习特征与SUVmax和肿瘤大小相关,解读时需结合传统影像特征。

局限性

  • 回顾性研究,样本量有限(189例)。
  • 仅使用内部和扩展测试队列,缺乏外部独立验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To develop an end-to-end deep learning (DL) model for non-invasively predicting non-small cell lung cancer (NSCLC) pathological subtypes based on 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) images, and to explore the potential value of DL technology.

MATERIALS AND METHODS: Preoperative 18F-FDG PET/CT images of 189 patients with NSCLC were retrospectively collected. The whole cohort was randomly divided into a training cohort, a validation cohort, and an internal/extended test cohort at the ratio of 6:2:2 after preprocessing the images. In the training and validation cohorts, seven DL models-Shufflenet, VGG16, Googlenet, Inception v3, Resnet50, Densenet201, and Mobilenet v2-were trained and optimized. The generalization ability and clinical utility of the optimal model were evaluated in the internal and extended test cohorts. Moreover, Spearman's correlation analysis was used to evaluate the correlation between DL features and traditional radiological features such as tumor size and maximum standardized uptake values (SUVmax).

RESULTS: Some DL features were significantly correlated with SUVmax and tumor size (P < 0.05). The Mobilenet v2 model achieved the best performance during the model development and validation phases. In the internal test group (area under the receiver operating characteristic curve [AUC]: 0.744, area under the precision-recall curve [AP]: 0.759) and extended test group (AUC: 0.767, AP: 0.768), the Mobilenet v2 model showed good generalization ability and reproducibility. Meanwhile, the decision curve analysis revealed that patients can benefit from the decisions made based on the Mobilenet v2 model.

CONCLUSION: DL models offer great potential for classifying NSCLC pathological subtypes. Specifically, the Mobilenet v2 model performs well at end-to-end non-invasive pathological subtype stratification of NSCLC.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhao, Su, Lyu, et al. Non-invasively Discriminating the Pathological Subtypes of Non-small Cell Lung Cancer with Pretreatment 18F-FDG PET/CT Using Deep Learning. Acad Radiol. 2023. PMID: 37117141. doi:10.1016/j.acra.2023.03.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。